Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -311,351 | -223,858 | -146,962 | -154,808 | -100,217 |
| Depreciation Amortization | -566 | -6,610 | -1,664 | 3,866 | 8,204 |
| Accounts receivable | N/A | 15,000 | -15,000 | N/A | 577 |
| Accounts payable and accrued liabilities | -1,974 | -307 | 2,038 | 253 | 54 |
| Other Working Capital | 15,266 | -23,970 | 2,682 | -37,623 | -61,923 |
| Other Operating Activity | 65,734 | 45,244 | 56,080 | 35,227 | 24,359 |
| Operating Cash Flow | $-232,891 | $-194,501 | $-102,826 | $-153,085 | $-128,946 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,449 | -12,838 | -34,480 | -2,836 | -1,597 |
| Purchase Of Investment | -1,007,628 | -901,226 | -189,151 | -445,972 | -456,404 |
| Sale Of Investment | 488,016 | 509,987 | 363,517 | 469,327 | 358,166 |
| Investing Cash Flow | $-521,061 | $-404,077 | $139,886 | $20,519 | $-99,835 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,494 | -1,576 | -76 | -1,130 | -849 |
| Common Stock Issued | 992,207 | 610,427 | 4,268 | 154,129 | 251,526 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -397 |
| Financing Cash Flow | $990,713 | $608,851 | $4,192 | $152,999 | $250,280 |
| Beginning Cash Position | 126,050 | 115,777 | 74,525 | 54,092 | 32,593 |
| End Cash Position | 362,811 | 126,050 | 115,777 | 74,525 | 54,092 |
| Net Cash Flow | $236,761 | $10,273 | $41,252 | $20,433 | $21,499 |
| Free Cash Flow | |||||
| Operating Cash Flow | -232,891 | -194,501 | -102,826 | -153,085 | -128,946 |
| Capital Expenditure | -1,449 | -12,838 | -34,480 | -2,836 | -1,597 |
| Free Cash Flow | -234,340 | -207,339 | -137,306 | -155,921 | -130,543 |